Shakti Emulsion


Published on

Published in: Technology, Business
  • Be the first to comment

No Downloads
Total views
On SlideShare
From Embeds
Number of Embeds
Embeds 0
No embeds

No notes for slide

Shakti Emulsion

  2. 2. CONTENTS: <ul><li>RECENT ADVANCE IN EMULSION </li></ul><ul><li>Multiple emulsion </li></ul><ul><li>Microemulsion </li></ul><ul><li>Self emulsifying drug delivery system </li></ul><ul><li>Nanoemulsion </li></ul>09/26/11 Shakti Suthar
  3. 3. Multiple emulsion 09/26/11 Shakti Suthar
  4. 4. Contents: <ul><li>Introduction </li></ul><ul><li>Method of preparation </li></ul><ul><li>Characterization of Multiple emulsion </li></ul><ul><li>Application </li></ul>09/26/11 Shakti Suthar
  5. 5. Introduction: <ul><li>Multiple emulsion systems are novel developments in the field of emulsion technology and are more complex type of dispersed system. </li></ul><ul><li>These are the emulsion systems in which the dispersed phase contain smaller droplets that have the same compositon as the external phase. </li></ul><ul><li>These made possible by the double emulsification hence the systems are also called as “double emulsion”. </li></ul><ul><li>Diameter of the droplets in a Multiple emulsion is in the range of o.5 to 3µm. </li></ul>09/26/11 Shakti Suthar
  6. 6. <ul><li>Like simple emulsion multiple emulsion are classified into two type. </li></ul><ul><li>1)O/W/O type </li></ul><ul><li>2)W/O/W type </li></ul><ul><li>The immiscible phase ,which separates the two miscible phase is known as “liquid membrane” and act as a diffusion barrier and semipermeable membrane for drugs or moities entrapped in the internal aqueous phase. </li></ul>09/26/11 Shakti Suthar
  7. 7. Methods of preparation <ul><li>Multiple emulsion systems can be formed by the reemulsification of a primary emulsion or they can be produced when an emulsion inverts from one type to another,eg.W/O to O/W. </li></ul><ul><li>Three methods for preparation: </li></ul><ul><li>1)Two step emulsification(Double emulsification) </li></ul><ul><li>2)Phase inversion technique(One step technique) </li></ul><ul><li>3)Membrane emulsification technique </li></ul>09/26/11 Shakti Suthar
  8. 8. <ul><li>1)Two step emulsification : </li></ul><ul><li>First prepare primary emulsion (W/O or O/W ) </li></ul><ul><li>Then it is reemulsified with an excess of aqueous or oil phase. </li></ul><ul><li>2)Phase inversion technique: </li></ul><ul><li>A queous phase containing hydrophilic emulsifier is added into the oil phase containing the lipophilic surfactant in a mixer at a rate of 5ml/min. </li></ul><ul><li>The mixer is rotate at 88rpm at room temperature. </li></ul><ul><li>When volume fraction of a queous solution containing hydrophilic emulsifier exceeds 0.7, the continuous oil phase is converted into aqueous phase containing number of small oil droplets. </li></ul>09/26/11 Shakti Suthar
  9. 9. <ul><li>3) Membrane emulsification technique </li></ul><ul><li>In this method a W/O emulsion(dispersed phase) is extruded into a an external aqueous phase(continuous phase) with a constant pressure through a porous glass membrane which should have controlled and homogenous pores. </li></ul><ul><li>The relationship between membrane pore size and droplet size of W/O/W emulsion is given by following equation : </li></ul><ul><li>Y=5.03X + O.19 </li></ul>09/26/11 Shakti Suthar
  10. 10. Characterization of Multiple emulsion : <ul><li>1)Macroscopic examination: </li></ul><ul><li>Colour </li></ul><ul><li>Consistency </li></ul><ul><li>Homogeneity </li></ul><ul><li>2)Average globule size and size distribution: </li></ul><ul><li>By using optical microscopy or phase contrast microscop. </li></ul><ul><li>By this technique, they are classified into </li></ul><ul><li>1)Course(>3 µm diameter) </li></ul><ul><li>2)Fine (1-3 µm diameter) </li></ul><ul><li>3)Micro-multiple emulsion (<1 µm diameter) </li></ul>09/26/11 Shakti Suthar
  11. 11. <ul><li>3) Area of interfaces: </li></ul><ul><li>The average globule diameter determine can be used in the calculation of the total area of interface using the formula: </li></ul><ul><li>S= 6 / d </li></ul><ul><li>4) Rheological evaluation: </li></ul><ul><li>It include 2 parameters: </li></ul><ul><li>Viscosity (By brookfield viscometer ) </li></ul><ul><li>Interfacial film strength (By Oscillatory surface rheometer) </li></ul>09/26/11 Shakti Suthar
  12. 12. <ul><li>5) Zeta potential measurement: </li></ul><ul><li>This is used to identify the charge of the droplets. It can be calculated by following equation: </li></ul><ul><li>ᶎ = 4 ᴨῃ ụ * 10 3 </li></ul><ul><li>ᵋ E </li></ul><ul><li>6) In vitro drug release: </li></ul><ul><li>By dialysis method using cellophane tubing. </li></ul>09/26/11 Shakti Suthar
  13. 13. <ul><li>Application : </li></ul><ul><li>Controlled and sustained drug delivery. </li></ul><ul><li>Drug targeting. </li></ul><ul><li>Vaccine adjuvant . </li></ul><ul><li>Immobilization of enzyme. </li></ul><ul><li>Cosmetic application. </li></ul><ul><li>As a preparative tool for microencapsulation technology. </li></ul><ul><li>Miscellaneous. </li></ul><ul><li>Protection action. </li></ul><ul><li>Taste masking. </li></ul><ul><li>Absorption enhancement through GIT. </li></ul>09/26/11 Shakti Suthar
  14. 14. <ul><li>Microemulsion </li></ul>09/26/11 Shakti Suthar
  15. 15. Contents: <ul><li>Introduction </li></ul><ul><li>Advantages </li></ul><ul><li>Disadvantages </li></ul><ul><li>Diffference </li></ul><ul><li>Preparation </li></ul><ul><li>Evaluation </li></ul><ul><li>Research work </li></ul>09/26/11 Shakti Suthar
  16. 16. <ul><li>Introduction: </li></ul><ul><li>Microemulsions are clear, stable, liquid mixtures of oil, water and surfactant, frequently in combination with a cosurfactant like short chain alcohol or amine. </li></ul><ul><li>Diameter of the droplets in a microemulsion is in the range of 0.1 to 10 µm. </li></ul><ul><li>The two basic types of microemulsions are </li></ul><ul><li>(1) o/w (oil dispersed in water) and </li></ul><ul><li>(2) w/o (water dispersed in oil). </li></ul>09/26/11 Shakti Suthar
  17. 17. Advantages: <ul><li>Thermodynamically stable </li></ul><ul><li>Act as a supersolvents of drug. </li></ul><ul><li>Diameter of droplets is less so they can be sterilized by filtration. </li></ul><ul><li>Due to small droplets,they have large interfacial area so the absorption of drug is more. </li></ul><ul><li>Same microemulsion can carry both lipophilic and hydrophilic drugs. </li></ul><ul><li>Because of thermodynamic stability,they are easy to prepare and require less energy during their preparation. </li></ul><ul><li>Formation of microemulsion is reversible. </li></ul>09/26/11 Shakti Suthar
  18. 18. Disadvantages: <ul><li>Use of large concentration of surfactant and cosurfactant necessary for solubilizing the nanodroplets. </li></ul><ul><li>Limited solubilizing capacity for high melting substances. </li></ul><ul><li>The surfactant must be non toxic for using pharmaceutical application. </li></ul><ul><li>Microemulsion stability is influenced by environmental parameters such as temperature and pH. These parameters change upon microemulsion delivery to patients. </li></ul>09/26/11 Shakti Suthar
  19. 19. Difference between Ordinary emulsion and Microemulsion: 09/26/11 Shakti Suthar Ordinary emulsion Microemulsion Size of globule: 0.5-50 µm 0.1-10 µm Appearance: Turbid Clear Thermodynamically: Stable but coalesce finally. More stable Viscosity: - Less compared to other emulsion. Preparation: It require high shear condition By simple mixing of the component and do not require high shear condition Surfactant concentration: 2-3 %Waight 6-8 %Waight Phases: 2 1
  20. 20. 09/26/11 Shakti Suthar
  21. 21. Preparation of microemulsion: <ul><li>Microemulsions are thermodynamically stable, so they can prepared simply by blending oil, water, surfactant and cosurfactant with mild agitation or mild heat. </li></ul><ul><li>Titrating the mixer of surfactant ,cosurfactant,and oil against the water till the clear solution is obtained. </li></ul><ul><li>If solution is still slight turbid then add some more amount of cosurfactant to get the clear solution. </li></ul>09/26/11 Shakti Suthar
  22. 22. 09/26/11 Shakti Suthar
  23. 23. Evaluation of microemulsion <ul><li>1)Percentage Transmittance : </li></ul><ul><li>Transparency of microemulsion formulation was determined by measuring percentage transmittance through U.V. Spectrophotometer. </li></ul><ul><li>2)Droplet Size Analysis: </li></ul><ul><li>By microscopic method </li></ul><ul><li>3)Zeta-Potential Determination: </li></ul><ul><li>4)Viscosity </li></ul><ul><li>5)Conductivity Measurements </li></ul><ul><li>6)Stability Studies: The optimized ME was stored at </li></ul><ul><li>three different temperature ranges for 6 months i.e., </li></ul><ul><li>refrigerating condition (2 0 C – 8 0 C), room temperature and elevated temperature (50 ± 2 0 C) and shelf life of the stored microemulsion system was evaluated by visual inspection (phase separation), % transmittance, Particle size and % Assay. </li></ul>09/26/11 Shakti Suthar
  24. 24. <ul><li>Research Work carried out on Microemulsions </li></ul><ul><li>Drug Name Route Purpose/Result </li></ul><ul><li>Flurbiprofen Parenteral Increased the solubility </li></ul><ul><li>Apormorphine HCl Transdermal Increased the permeability </li></ul><ul><li>Ketoprofen Transdermal Enhancement of permeability </li></ul><ul><li>Prilocainne-HCL Transdermal Increased the solubility </li></ul><ul><li>Estradiol Transdermal Improvement in solubilization </li></ul><ul><li>Aceclofenac Dermatological Increased the solubility </li></ul><ul><li>Piroxicam Oral Increased the solubility </li></ul><ul><li>Diclofenac Transdermal Permeability enhancement </li></ul><ul><li>Dexamethasone Topical Ocular Enhanced the Bioavailability </li></ul><ul><li>Chloramphenicol Ocular Increased the solubility </li></ul><ul><li>Ibuprofen Parenteral Increased the solubility </li></ul><ul><li>Sumatriptan Intranasal Enhanced the Bioavailability </li></ul><ul><li>Ibuprofen Topical Increasing the solubility </li></ul>09/26/11 Shakti Suthar
  25. 25. <ul><li>SELF EMULSIFYING DRUG DELIVERY SYSTEM </li></ul>09/26/11 Shakti Suthar
  26. 26. Contents: <ul><li>Introduction </li></ul><ul><li>Need of SEDDS </li></ul><ul><li>Composition of SEDDS </li></ul><ul><li>Formulation of SEDDS </li></ul><ul><li>Characterization of SEDDS </li></ul><ul><li>Application </li></ul><ul><li>Drawback </li></ul>09/26/11 Shakti Suthar
  27. 27. Introduction: <ul><li>Self-emulsifying drug delivery systems (SEDDS) are usually used to improve the bioavailability of hydrophobic drugs. </li></ul><ul><li>Approximately 40% of new chemical entities exhibit poor aqueous solubility and present a major challenge to modern drug delivery system, because of their low bioavailability. </li></ul><ul><li>SEDDS is ideally an isotropic mixture of oils and surfactants and sometimes co solvents. </li></ul><ul><li>The multi-component delivery systems have optimized by evaluating their ability to self-emulsify when introduced to an aqueous medium under gentle agitation, and by determination of particle size of the resulting emulsion . </li></ul>09/26/11 Shakti Suthar
  28. 28. <ul><li>Upon oral administration,these systems form fine (micro) emulsions in the gastrointestinal tract (GIT) with mild agitation provided by gastric mobility. </li></ul><ul><li>Fine oil droplets would pass rapidly from the stomach and promote wide distribution of the drug throughout the GI tract, thereby minimizing the irritation frequently encountered during extended contact between bulk drug substances and the gut wall. </li></ul><ul><li>When compared with emulsions, which are sensitive and metastable dispersed forms, SEDDS are physically stable formulations that are easy to manufacture. </li></ul>09/26/11 Shakti Suthar
  29. 29. Need of SEDDS : <ul><li>Oral delivery of poorly water-soluble compounds is to pre-dissolve the compound in a suitable solvent and fill the formulation into capsules. </li></ul><ul><li>The main benefit of this approach is that pre-dissolving the compound overcomes the initial rate limiting step of particulate dissolution in the aqueous environment within the GI tract. </li></ul>09/26/11 Shakti Suthar
  30. 30. Composition of SEDDS: <ul><li>1)Oils. </li></ul><ul><li>2)Surfactant </li></ul><ul><li>3)Cosolvents </li></ul><ul><li>4)Medicament </li></ul>09/26/11 Shakti Suthar
  31. 31. <ul><li>1)Oils: </li></ul><ul><li>Oils can solubilize the lipophilic drug in a specific amount. </li></ul><ul><li>It is the most important excipient because it can facilitate self-emulsification and increase the fraction of lipophilic drug transported via the intestinal lymphatic system, thereby increasing absorption from the GI tract. </li></ul><ul><li>Mainly triglycerides are use. </li></ul><ul><li>2)Surfactant: </li></ul><ul><li>Nonionic surfactants with high hydrophilic–lipophilic balance (HLB) values are used in formulation of SEDDSs. </li></ul>09/26/11 Shakti Suthar
  32. 32. <ul><li>The usual surfactant strength ranges between 30–60% w/w of the formulation in order to form a stable SEDDS </li></ul><ul><li>e.g., Tween, Labrasol, Labrafac CM 10, Cremophore, etc.). </li></ul><ul><li>3)Cosolvents: </li></ul><ul><li>It may help to dissolve large amounts of hydrophilic surfactants or the hydrophobic drug in the lipid base. These solvents sometimes play the role of the cosurfactant in the microemulsion systems. </li></ul><ul><li>Eg.diehylene glycol monoethyl ether (transcutol), propylene glycol, polyethylene glycol, polyoxyethylene, propylene carbonate, tetrahydrofurfuryl alcohol,polyethylene glycol ether (Glycofurol), etc . </li></ul>09/26/11 Shakti Suthar
  33. 33. Formulation of SEDDSs :   <ul><li>The following should be considered in the formulation of a SEDDS:   </li></ul><ul><li>The solubility of the drug in different oil, surfactants and cosolvents. </li></ul><ul><li>The selection of oil, surfactant and cosolvent based on the solubility of the drug and the preparation of the phase diagram. </li></ul><ul><li>For preparation following steps are involve </li></ul><ul><li>1) Preparation of phase diagram </li></ul><ul><li>2) Solubilizing a poorly water-soluble drug and/or pharmaceutical ingredient, in a mixture of surfactant , cosurfactant and solvent. </li></ul>09/26/11 Shakti Suthar
  34. 34. <ul><li>Now mix the oil phase suitably prepared, if necessary,by heating or other preparatory means, to the solubilized drug formulation and thoroughly mixed. </li></ul><ul><li>3) The emulsion can then be added to a </li></ul><ul><li>suitable dosage form such as soft or hard-filled gelatin capsules and allowed to cool . </li></ul>09/26/11 Shakti Suthar
  35. 35. Characterization of SEDDSs: <ul><li>Visual assessment . This may provide important information about the self-emulsifying and microemulsifying property of the mixture and about the resulting dispersion. </li></ul><ul><li>Turbidity Measurement . This is to identify efficient self-emulsification by establishing whether the dispersion reaches equilibrium rapidly and in a reproducible time.   </li></ul><ul><li>Droplet Size . This is a crucial factor in self-emulsification performance because it determines the rate and extent of drug release as well as the stability of the emulsion. Photon correlation spectroscopy, microscopic techniques or a Coulter Nanosizer are mainly used for the determination of the emulsion droplet size. The reduction of the droplet size to values below 50 μm leads to the formation of SMEDDSs, which are stable and clear o/w dispersions. </li></ul>09/26/11 Shakti Suthar
  36. 36. <ul><li>Zeta potential measurement . This is used to identify the charge of the droplets. In conventional SEDDSs, the charge on an oil droplet is negative due to presence of free fatty acids. </li></ul><ul><li>Determination of emulsification time . Self-emulsification time, dispersibility, appearance and flowability was observed. </li></ul>09/26/11 Shakti Suthar
  37. 37. Applications <ul><li>Improvement in Solubility and bioavailability. </li></ul><ul><li>Eg. Ketoprofen </li></ul><ul><li>Protection against Biodegradation </li></ul><ul><li>Eg .Aspirin </li></ul><ul><li>Drawbacks of SEDDS </li></ul><ul><li>Chemical instabilities of drugs and high surfactant concentrations. The large quantity of surfactant in self-emulsifying formulations (30-60%) irritates GIT. Consequently, the safety aspect of the surfactant vehicle had to be considered. </li></ul><ul><li>Volatile cosolvents in the conventional self-emulsifying formulations are known to migrate into the shells of soft or hard gelatin capsules, resulting in the precipitation of the lipophilic drugs. </li></ul>09/26/11 Shakti Suthar
  38. 38. NANOEMULSION 09/26/11 Shakti Suthar
  39. 39. Contents: <ul><li>Introduction </li></ul><ul><li>Advantages </li></ul><ul><li>Method of preparation </li></ul><ul><li>Characterization </li></ul><ul><li>Marketed products </li></ul><ul><li>Patented NE </li></ul><ul><li>Application </li></ul>09/26/11 Shakti Suthar
  40. 40. Introduction: <ul><li>Nanoemulsion are thermodynamically stable system in which the two immisible liquid (water and oil)are mix to form a single phase by means of appropriate surfactant . </li></ul><ul><li>Diameter of the droplets in a nanoemulsion is in the range of 20 to 200 nm. </li></ul>09/26/11 Shakti Suthar
  41. 41. Advantages: <ul><li>High surface area and free energy then macroemulsion that make them effective transport system. </li></ul><ul><li>NEs do not show the problem of creaming, flocculation, coalescence and sedimentation which are associated with macroemulsion. </li></ul><ul><li>It can be formulated in variety of formulation such as foam,spray,cream,liquid etc. </li></ul><ul><li>NEs are non toxic and non irritant so they can be easily applied to skin and mucous membrane. </li></ul><ul><li>NEs are formulated by the surfactant which are approved by the GRAAS,so they can be given by the enteric route. </li></ul><ul><li>NEs do not damage the animal and human cells hence are suitable for human and veterinary purpose </li></ul>09/26/11 Shakti Suthar
  42. 42. Method of preparation of NEs <ul><li>1)High pressure homoginization: </li></ul><ul><li>By high pressure homoginizer or piston homoginizer which produce NEs of exrtemly low particle size upto 1 nm. </li></ul><ul><li>2)Microfluidization: </li></ul><ul><li>This make use of microfluidizer. </li></ul><ul><li>This device use high pressure positive displacement pump(500-20000 psi) which force the product through the interaction chamber which consist of small micro channel. </li></ul><ul><li>Product flow throgh the micro channel on to the impigment resulting in the formation of nano size droplet. </li></ul>09/26/11 Shakti Suthar
  43. 43. 09/26/11 Shakti Suthar
  44. 44. Characterization of NEs: <ul><li>Transmission eletron microscopy </li></ul><ul><li>Drolet size analysis </li></ul><ul><li>Viscosity </li></ul><ul><li>Refractive index </li></ul><ul><li>Skin irritation test </li></ul><ul><li>Thermodynamic stability study </li></ul><ul><li>Surface characteristics </li></ul>09/26/11 Shakti Suthar
  45. 45. Marketed products: 09/26/11 Shakti Suthar Drug Brand Manufacturer Indication Propofol Diprivan Astra zeneca Anesthatic Dexamethazone Limethasonn Mitsubishi pharmaceutical, Japan Steroids Palmitate alprostadil Liple Mitsubishi pharmaceutical, Japan Vasodilator Flubriprofen axetil Ropion Kaken pharmaceutical, Japan NSAIDS Vitamines A,D,E,K Vitalipid Fresenius kabi,Europe Parenteral nutrition
  46. 46. Patented nanoemulsions: <ul><li>Patent name :Method of preventing and treating microbial infection.Assigne: nano bio corporation US.Patent no-6506803. </li></ul><ul><li>Patent name :NE based on phosphoric acid fatty ester and use in cosmetics. Assigne:L,orial(Paris) US.Patent no-6275150. </li></ul><ul><li>Patent name :NE based on ethylene oxide and propylene oxide. </li></ul>09/26/11 Shakti Suthar
  47. 47. Application: <ul><li>Use in cosmetics </li></ul><ul><li>As a antimicrobial nanoemulsion </li></ul><ul><li>Use in cell culture technology </li></ul><ul><li>As a non toxic disinfectant cleaner </li></ul><ul><li>Use in cancer therapy </li></ul><ul><li>For improved oral delivery of poorly soluble drugs. </li></ul><ul><li>As a vehicle for transdermal delivery </li></ul>09/26/11 Shakti Suthar
  48. 48. References: <ul><li>1) Advances in controlled and novel drug delivery. </li></ul><ul><li>By N.K.Jain </li></ul><ul><li>2) Targeted and controlled drug delivery </li></ul><ul><li>By S.P.Vyas and R.K.Khar </li></ul><ul><li>3) Nano emulsion: A pharmaceuticle review. </li></ul><ul><li>http:/ </li></ul><ul><li>4) Review Article :Microemulsions: a novel drug carrier system.International Journal of Drug Delivery Technology 2009; 1(2): 39-41 </li></ul>09/26/11 Shakti Suthar
  49. 49. <ul><li>5) Self emulsifying drug delivery system: an approach to enhance bioavailability International Journal of Pharma Research and Development – Online </li></ul><ul><li> </li></ul><ul><li>6) TOPICAL REVIEW: nanoemulsions: </li></ul><ul><li>Formation, structure, and physical properties. Journal of physics: condensed matter 18 (2006) r635–r666 </li></ul><ul><li>Stacks.Iop.Org/jphyscm/18/R633 </li></ul>09/26/11 Shakti Suthar
  50. 50. Study question: <ul><li>Write a note on Self-emulsifying drug delivery systems. (GTU-remidial December 2010) </li></ul>09/26/11 Shakti Suthar
  51. 51. 09/26/11 Shakti Suthar